GLG News by Restylane Users for Wrinkles: Dermatologists

I do not believe that Vaniqa will have a negative effect on Laser hair removal as its efficacy is only temporary. In fact we use it as an adjunct for patients with resistant areas. Its use may actually enhance the use of Laser devices as they offer permanence. The products use may be increasing as more...

Advitech's launch of Dermylex will not have much of an impact on the psoriasis market. This is due to the fact that the product has minimal studies to back it up, and the company will rely on testimonials. This is not an effective way of marketing to physicians, and is difficult with patients....

Depending on the accuracy and cost of the technology, this device could be a useful and welcome tool in melanoma diagnosis.  To be considered useful, the Melafind device must increase melanoma recognition without a significant false negative rate.  In other words, the machines ability to catch...

If Melafinds phase three study results are positive then physicians will in general be receptive. The only issues are: 1. Ease of use/time to scan 2. Ability for non physician personnel to be trained to use the technology. 3. cost 4. Insurance reimbursement The technology may have more use at larger...

The new Modus product "without hydroquinone" cannot be fully evaluated on the basis of the currently available information. Decisions based on the opinions of a "Beauty Editor", and 6 years worth of studies with only 4 patients, are tenuous at best, and laughable at worst. It will be difficult to unseat...

Discount cosmetic surgery is already here, but not via large commercial companies.  Retention of actual plastic and reconstructive surgeons may be difficult if they are not paying well.  There is a place for this, however the solo practitioner will continue to have word of mouth and a place....

All that glitters is not gold...but some might be! Anti-oxidants are the promise of saving our "hides"!

Keep Hydroquinones Around!

The possible ban of over the counter hydroquinone skin bleaching agents may be premature. We have used these agents for 20 years without any significant side effects including ochronosis or paradoxical darkening of the skin. These agents are only modestly effective at best. Most patients still...

The company hopes to apply for European regulatory approval next year, with U.S. market approval and launch to follow. The current price of the device is 15,000 EUR. This device promises to be a remarkable time and money saver for medicine. Approximately 80-95% of lesions excised by dermatologists prove...